According to our findings, it is possible that an increase in extrasynaptic NR2B function may arise in AD patients due to an increase in extrasynaptic receptors, which could facilitate an increase in neurotransmission from glutamate spillover [15, 19, 33, 46, 63]. The gene discussed is GRIN2B; the disease is Alzheimer disease.